Advertisement News Archives - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

News

August 17, 2022

Senda raises funds to advance programmable medicines platform development

Senda Biosciences has raised $123m in Series C financing round to advance the development of its programmable medicines’ platform into clinical testing.

Senda raises funds to advance programmable medicines platform development